Triazolo compounds useful as diacylglycerol acyltransferase1 inhibitor – WO2009126624

Bibliography

• Lehner R, Kuksis A. Biosynthesis of triacylglycerols. Prog Lipid Res 1996;35:169-201
   PubMed Web of Science ®Google Scholar
• Cases S, Smith SJ, Zheng Y-W, Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci USA 1998;95:13018-23
   PubMed Web of Science ®Google Scholar
• Oelkers P, Behari A, Cromley D, Characterization of two human genes encoding acyl coenzyme A: cholesterol acyltransferase-related enzymes. J Biol Chem 1998;273:26765-71
   PubMed Web of Science ®Google Scholar
• Cases S, Stone SJ, Zhou P, Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 2001;276:38870-6
   PubMed Web of Science ®Google Scholar
• Stone SJ, Myers HM, Watkins SM, Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem 2004;279:11767-76
   PubMed Web of Science ®Google Scholar
• Smith SJ, Cases S, Jensen DR, Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking DGAT. Nat Genet 2000;25:87-90
   PubMed Web of Science ®Google Scholar
• Chen HC, Smith SJ, Ladha Z, Increased insulin and leptin sensitivity in mice lacking acyl-CoA: diacylglycerol acyltransferase 1. J Clin Invest 2002;109:1049-55
   PubMed Web of Science ®Google Scholar
• Chen HC, Ladha Z, Smith SJ, Analysis of energy expenditure at different ambient temperatures in mice lacking DGAT1. Am J Physiol Endocrinol Metab 2003;284:E213-8
   Web of Science ®Google Scholar
• Chen HC, Farese RV Jr. Inhibition of triglyceride synthesis as a treatment strategy for obesity. Arterioscler Thromb Vasc Biol 2005;25:482-6
   PubMed Web of Science ®Google Scholar
• Seethala R, Peterson T, Dong J, A simple homogeneous scintillation proximity assay for acyl-coenzyme A: diacylglycerol acyltransferase. Anal Biochem 2008;383:144-50
   PubMed Web of Science ®Google Scholar
• King AJ, Judd AS, Souers AJ. Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents. Expert Opin Ther Pat 2010;20:19-29
   PubMed Web of Science ®Google Scholar
• Bayer Pharmaceuticals Corporation. Preparation and use of aryl alkyl acid derivatives for the treatment of obesity. WO100881; 2004
   Google Scholar
• Bayer Pharmaceuticals Co. Preparation of aryl alkyl acid derivatives for the treatment of obesity and related diseases. WO06113919; 2006
   Google Scholar
• Japan Tobacco, Inc. Anorectic compounds. WO072740; 2005
   Google Scholar
• Takeda Pharmaceutical Company. Furan or thiophene derivative and medicinal use thereof. WO022551; 2004
   Google Scholar
• Astrazeneca AB. Use of sulfonamide compounds for the treatment of diabetes and/or obesity. WO044250; 2005
   Google Scholar
• F. Hoffmann-La Roche AG. Inhibitors of diacylglycerol acyltransferase (DGAT). WO082010; 2006
   Google Scholar
• F. Hoffmann-La Roche AG. Diacylglycerol acyltransferase inhibitors. WO120125; 2006
   Google Scholar
• VIA Pharmaceuticals, Inc. 1-(Indazol-5-yl)-ureas as diacylglycerol acyltransferase inhibitors. WO071483; 2009
   Google Scholar
• Bristol-Myers Squibb Co. Triazolopyridine compounds useful as DGAT1 inhibitors. WO126861; 2009
   Google Scholar
• Taisho Pharmaceutical Co., Ltd. Heteroarylbenzene compounds. WO011285; 2009
   Google Scholar
• Astrazeneca AB. Oxadiazole derivatives as DGAT inhibitors. WO024821; 2009
   Google Scholar
• Tularic, Inc., Japan Tobacco, Inc. Preparation of pyrrolo[1,2-b]pyridazines for use in pharmaceutical compositions which modulate the activity of proteins involved in lipid metab. and cell proliferation. WO05013907; 2005
   Google Scholar
• Novartis AG. Organic compounds. WO007046; 2010
   Google Scholar
• Novartis AG. Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as DGAT1 inhibitors. WO040410; 2009
   Google Scholar
• Available from: http://www.prdomain.com/companies/P/Pfizer/newsreleases/82845084.htm
   Google Scholar
• Available from: http://clinicaltrials.gov/ct2/show/NCT00959426?term=bristol+myers+diabete+pfizer&rank=1
   Google Scholar
• Available from: http://www.prdomain.com/companies/P/Pfizer/newsreleases/82845084.htm
   Google Scholar
• Matsuda D, Tomoda H. DGAT inhibitors for obesity. Curr Opin Investig Drugs 2007;8:836-41
   PubMedGoogle Scholar
• Tomoda H, Omura S. Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. Pharmacol Ther 2007;115:375-89
   PubMed Web of Science ®Google Scholar
• Tomoda H, Ito M, Tabata N, Amidepsines, inhibitors of diacylglycerol acyltransferase produced by Humicola sp. FO-2942. I. Production, isolation and biological properties. J Antibiot 1995;48:937-41
   PubMedGoogle Scholar
• Tomoda H, Tabata N, Ito M, Amidepsines, inhibitors of diacyl glycerol acyltransferase produced by Humicola sp. FO-2942. II. Structure elucidation of amidepsines A, B and C. J Antibiot 1995;48:942-7
   PubMedGoogle Scholar
• Tomoda H, Yamaguchi Y, Tabata N, Amidepsine E, an inhibitor of diacylglycerol acyltransferase produced by Humicola sp. FO-5969. J Antibiot 1996;49:929-31
   PubMedGoogle Scholar
• Omura S, Tomoda H, Tabata N, Roselipins, novel fungal metabolites having a highly methylated fatty acid modified with a mannose and an arabinitol. J Antibiot 1999;52:586-9
   PubMedGoogle Scholar
• Tomoda H, Ohyama Y, Abe T, Roselipins, inhibitors of diacylglycerol acyltransferase, produced by Gliocladium roseum KF-1040. J Antibiot 1999;52:689-94
   PubMedGoogle Scholar
• Tabata N, Ohyama Y, Tomoda H, Structure elucidation of roselipins, inhibitors of diacylglycerol acyltransferase produced by Gliocladium roseum KF-1040. J Antibiot 1999;52:815-26
   PubMedGoogle Scholar
• Elix JA, Jayanthi VK, Leznoff CC. 2,4-Di-O-methylgyrophoric acid and 2,4,5-tri-O-methylhiascic acid. New tridepsides from Parmelia damaziana. Aust J Chem 1981;34:1757-61
   Google Scholar
• Tabata N, Ito M, Tomoda H, Xanthohumols, diacylglycerol acyltransferase inhibitors, from Humulus lupulus. Phytochemistry 1997;46:683-7
   PubMed Web of Science ®Google Scholar
• Ko JS, Rho MC, Chung MY, Quinolone alkaloids, diacylglycerol acyltransferase inhibitors from the fruits of Evodia rutaecarpa. Planta Med 2002;68:1131-3
   PubMedGoogle Scholar
• Ko JS, Ko JS, Ryu SY, Inhibitory activity of diacylglycerol acyltransferase by tanshinones from the root of Salvia miltiorrhiza. Arch Pharm Res 2002;25:446-8
   PubMed Web of Science ®Google Scholar
• Lee SW, Kim K, Rho MC, New polyacetylenes, DGAT inhibitors from the roots of Panax ginseng. Planta Med 2004;70:197-200
   PubMedGoogle Scholar
• Chung MY, Rho MC, Ko JS, In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens. Planta Med 2004;70:258-60
   PubMed Web of Science ®Google Scholar
• Dat NT, Cai XF, Rho MC, The inhibition of diacylglycerol acyltransferase by terpenoids from Youngia koidzumiana. Arch Pharm Res 2005;28:164-8
   PubMed Web of Science ®Google Scholar
• Chung MY, Rho MC, Lee SW, Inhibition of diacylglycerol acyltransferase by betulinic acid from Alnus hirsuta. Planta Med 2006;72:267-69
   PubMedGoogle Scholar
• Lee SW, Rho MC, Park HR, Inhibition of diacylglycerol acyltransferase by alkamides isolated from the fruits of Piper longum and Piper nigrum. J Agric Food Chem 2006;54:9759-63
   PubMed Web of Science ®Google Scholar
• Inokoshi J, Kawamoto K, Takagi Y, Expression of two human acyl-CoA: diacylglycerol acyltransferase isozymes in yeast and selectivity of microbial inhibitors toward the isozymes. J Antibiot (Tokyo) 2009;62:51-4
   PubMedGoogle Scholar
• Stone SJ, Myers HM, Watkins SM, Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem 2004;279:11767-76
   PubMed Web of Science ®Google Scholar
• Yu XX, Murray SF, Pandey SK, Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 2005;42:362-71
   PubMed Web of Science ®Google Scholar
• Koliwad SK, Streeper RS, Monetti M, DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. J Clin Invest 2010;120:756-67
   PubMed Web of Science ®Google Scholar
• Listenberger LL, Han X, Lewis SE, Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 2003;100:3077-82
   PubMed Web of Science ®Google Scholar